Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)

Christina M. Eckhardt; Matthew J. Cummings; Kartik N. Rajagopalan; Sarah Borden; Zachary C. Bitan; Allison Wolf; Alex Kantor; Thomas Briese; Benjamin J. Meyer; Samuel D. Jacobson; Dawn Scotto; Nischay Mishra; Neena M. Philip; Brie A. Stotler; Joseph Schwartz; Beth Shaz; Steven L. Spitalnik; Andrew Eisenberger; Eldad A. Hod Jessica Justman; Ken Cheung; W. Ian Lipkin; Max R. O’Donnell

doi:10.1186/s13063-020-04877-z

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)

Christina M. Eckhardt, Matthew J. Cummings, Kartik N. Rajagopalan, Sarah Borden, Zachary C. Bitan, Allison Wolf, Alex Kantor, Thomas Briese, Benjamin J. Meyer, Samuel D. Jacobson, Dawn Scotto, Nischay Mishra, Neena M. Philip, Brie A. Stotler, Joseph Schwartz, Beth Shaz, Steven L. Spitalnik, Andrew Eisenberger, Eldad A. Hod Jessica Justman, Ken CheungW. Ian Lipkin, Max R. O’Donnell

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Original language	English (US)
Article number	927
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-020-04877-z
State	Published - Dec 2020
Externally published	Yes

ASJC Scopus subject areas

Medicine (miscellaneous)
Pharmacology (medical)

Access to Document

10.1186/s13063-020-04877-z

Fingerprint

Dive into the research topics of 'Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)'. Together they form a unique fingerprint.

Cite this

Eckhardt, C. M., Cummings, M. J., Rajagopalan, K. N., Borden, S., Bitan, Z. C., Wolf, A., Kantor, A., Briese, T., Meyer, B. J., Jacobson, S. D., Scotto, D., Mishra, N., Philip, N. M., Stotler, B. A., Schwartz, J., Shaz, B., Spitalnik, S. L., Eisenberger, A., Hod Jessica Justman, E. A., ... O’Donnell, M. R. (2020). Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y). Trials, 21(1), Article 927. https://doi.org/10.1186/s13063-020-04877-z

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y). / Eckhardt, Christina M.; Cummings, Matthew J.; Rajagopalan, Kartik N. et al.
In: Trials, Vol. 21, No. 1, 927, 12.2020.

Research output: Contribution to journal › Comment/debate › peer-review

Eckhardt, CM, Cummings, MJ, Rajagopalan, KN, Borden, S, Bitan, ZC, Wolf, A, Kantor, A, Briese, T, Meyer, BJ, Jacobson, SD, Scotto, D, Mishra, N, Philip, NM, Stotler, BA, Schwartz, J, Shaz, B, Spitalnik, SL, Eisenberger, A, Hod Jessica Justman, EA, Cheung, K, Lipkin, WI & O’Donnell, MR 2020, 'Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)', Trials, vol. 21, no. 1, 927. https://doi.org/10.1186/s13063-020-04877-z

Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A et al. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y). Trials. 2020 Dec;21(1):927. doi: 10.1186/s13063-020-04877-z

Eckhardt, Christina M. ; Cummings, Matthew J. ; Rajagopalan, Kartik N. et al. / Correction to : Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y). In: Trials. 2020 ; Vol. 21, No. 1.

@article{752ba02778dd49b183d00f988449cb73,

title = "Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)",

abstract = "An amendment to this paper has been published and can be accessed via the original article.",

author = "Eckhardt, {Christina M.} and Cummings, {Matthew J.} and Rajagopalan, {Kartik N.} and Sarah Borden and Bitan, {Zachary C.} and Allison Wolf and Alex Kantor and Thomas Briese and Meyer, {Benjamin J.} and Jacobson, {Samuel D.} and Dawn Scotto and Nischay Mishra and Philip, {Neena M.} and Stotler, {Brie A.} and Joseph Schwartz and Beth Shaz and Spitalnik, {Steven L.} and Andrew Eisenberger and {Hod Jessica Justman}, {Eldad A.} and Ken Cheung and Lipkin, {W. Ian} and O{\textquoteright}Donnell, {Max R.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

doi = "10.1186/s13063-020-04877-z",

language = "English (US)",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)

AU - Eckhardt, Christina M.

AU - Cummings, Matthew J.

AU - Rajagopalan, Kartik N.

AU - Borden, Sarah

AU - Bitan, Zachary C.

AU - Wolf, Allison

AU - Kantor, Alex

AU - Briese, Thomas

AU - Meyer, Benjamin J.

AU - Jacobson, Samuel D.

AU - Scotto, Dawn

AU - Mishra, Nischay

AU - Philip, Neena M.

AU - Stotler, Brie A.

AU - Schwartz, Joseph

AU - Shaz, Beth

AU - Spitalnik, Steven L.

AU - Eisenberger, Andrew

AU - Hod Jessica Justman, Eldad A.

AU - Cheung, Ken

AU - Lipkin, W. Ian

AU - O’Donnell, Max R.

PY - 2020/12

Y1 - 2020/12

N2 - An amendment to this paper has been published and can be accessed via the original article.

AB - An amendment to this paper has been published and can be accessed via the original article.

UR - http://www.scopus.com/inward/record.url?scp=85096144682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096144682&partnerID=8YFLogxK

U2 - 10.1186/s13063-020-04877-z

DO - 10.1186/s13063-020-04877-z

M3 - Comment/debate

C2 - 33203476

AN - SCOPUS:85096144682

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 927

ER -

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial (Trials, (2020), 21, 1, (499), 10.1186/s13063-020-04422-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this